These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 3544373

  • 1. OKT3 treatment of steroid-resistant renal allograft rejection.
    Thistlethwaite JR, Gaber AO, Haag BW, Aronson AJ, Broelsch CE, Stuart JK, Stuart FP.
    Transplantation; 1987 Feb; 43(2):176-84. PubMed ID: 3544373
    [Abstract] [Full Text] [Related]

  • 2. Use of a brief steroid trial before initiating OKT3 therapy for renal allograft rejection.
    Thistlethwaite JR, Stuart JK, Mayes JT, Gaber AO, Stuart FP.
    Am J Kidney Dis; 1988 Feb; 11(2):94-8. PubMed ID: 3277413
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection.
    Thistlethwaite JR, Cosimi AB, Delmonico FL, Rubin RH, Talkoff-Rubin N, Nelson PW, Fang L, Russell PS.
    Transplantation; 1984 Dec; 38(6):695-701. PubMed ID: 6390834
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Experience with OKT3 in vascularized pancreas transplantation.
    Sollinger HW, Stratta RJ.
    Am J Kidney Dis; 1988 Feb; 11(2):145-8. PubMed ID: 3277405
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Delayed response to orthoclone OKT3 treatment for renal allograft rejection resistant to steroid and antilymphocyte globulin.
    Oh CS, Sollinger HW, Stratta RJ, Kalayoglu M, Belzer FO.
    Transplantation; 1988 Jan; 45(1):65-7. PubMed ID: 3276065
    [Abstract] [Full Text] [Related]

  • 9. Induction immunosuppression with antilymphocyte globulin or OKT3 in cadaver kidney transplantation. Results of a single institution prospective randomized trial.
    Hanto DW, Jendrisak MD, So SK, McCullough CS, Rush TM, Michalski SM, Phelan D, Mohanakumar T.
    Transplantation; 1994 Feb; 57(3):377-84. PubMed ID: 8108873
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A prospective randomized trial of prednisone versus no prednisone maintenance therapy in cyclosporine-treated and azathioprine-treated renal transplant patients.
    Schulak JA, Mayes JT, Moritz CE, Hricik DE.
    Transplantation; 1990 Feb; 49(2):327-32. PubMed ID: 2407003
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A comparison of OKT3 monoclonal antibody and corticosteroids in the treatment of acute renal allograft rejection.
    Deierhoi MH, Barber WH, Curtis JJ, Julian BA, Luke RG, Hudson S, Barger BO, Diethelm AG.
    Am J Kidney Dis; 1988 Feb; 11(2):86-9. PubMed ID: 3277412
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Early use of OKT3 monoclonal antibody in renal transplantation to prevent rejection.
    Norman DJ, Shield CF, Barry J, Bennett WM, Henell K, Kimball J, Funnell B, Hubert B.
    Am J Kidney Dis; 1988 Feb; 11(2):107-10. PubMed ID: 3277400
    [Abstract] [Full Text] [Related]

  • 20. Prophylactic use of OKT3 in immunologic high-risk cadaver renal transplant recipients.
    Schroeder TJ, First MR, Mansour ME, Alexander JW, Penn I.
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):14-8. PubMed ID: 2510506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.